Focus on the Patient: The Digital Evolution of IRT
Cenduit has benefited greatly from the relationship we have with our parent companies, from Quintiles’ clinical development experience to Thermo Fisher Scientific’s clinical supply chain know-how.
Cenduit has benefited greatly from the relationship we have with our parent companies, from Quintiles’ clinical development experience to Thermo Fisher Scientific’s clinical supply chain know-how. Their knowledge continues to be important for us in the development of innovative Interactive Response Technology (IRT) solutions that address the needs of CROs and sponsors in a landscape that is constantly evolving.
Two years ago, Quintiles released a
Delving deeper into this theme, Cenduit developed a
In fact, all three survey results showed clear parallels from both patients and clinical trial sites regarding
- Patients aren’t always returning medications and sometimes save it for future use, impacting the trial’s drug accountability process.
- Sites find it useful to have real-time tracking of the investigational product. However, even if sites can do this, it is difficult for them to provide accurate data if the unused medication is never returned to the site.
The underlining notion from these findings, in addition to our discussions with customers, was that sites simply wanted to maximize the time they have devoted to their patients. Thus, we needed to incorporate the same mindset when it came to IRT solutions for these clinical trial sites.
Drug accountability is a fundamental and intricate process in clinical trials that sites are required to perform, so this became a key concentration for us in the development of a
Breaking the mold of traditional systems, the website allows sites to do things they previously hadn’t been able to do, generating quicker transactions, integrating custom reporting tools, embedding role-specific user interfaces (rather than one size fits all) and providing 24/7 access to the global help desk through the web chat feature. Our ability to engage with patients through digital patient reminders also further reduced efforts of the clinical coordinator, especially when it came to long-term extension trial periods to ensure stronger data and a more successful trial.
By opening up the doors to new processes in IRT that aligned directly with feedback we received from sites, we were able to ensure this new platform was more than just another IRT system. This attentive approach to sites in conjunction with new trends in areas like technology is key to maximizing value for sponsors using IRT services. From harnessing the latest digital trends, to ensuring integration with
Grant Dietrich is Director of Account Management for Cenduit.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- Digital Measures of Health: What’s in it for Patients?
April 8th 2025